bisoprolol has been researched along with Leishmaniasis, Visceral in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrari, I | 1 |
| Levin, MJ | 1 |
| Wallukat, G | 1 |
| Elies, R | 1 |
| Lebesgue, D | 1 |
| Chiale, P | 1 |
| Elizari, M | 1 |
| Rosenbaum, M | 1 |
| Hoebeke, J | 1 |
1 other study available for bisoprolol and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor.
Topics: Amino Acid Sequence; Animals; Animals, Newborn; Antibodies, Protozoan; Antigens, Protozoan; Autoanti | 1995 |